Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion

Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly

(2015) Elena Gammella et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

An Evaluation of the Correlation between Hepcidin Serum Levels and Disease Activity in Inflammatory Bowel Disease

(2015) Zehra Betül Paköz et al.   Gastroenterology Research and Practice

Erythroferrone contributes to recovery from anemia of inflammation

(2014) L. Kautz et al.   BLOOD

Intestinal Inflammation Modulates Expression of the Iron-Regulating Hormone Hepcidin Depending on Erythropoietic Activity and the Commensal Microbiota

(2014) N. K. N. Shanmugam et al.   JOURNAL OF IMMUNOLOGY

Identification of erythroferrone as an erythroid regulator of iron metabolism

(2014) Léon Kautz et al.   NATURE GENETICS

Serum Hepcidin in Inflammatory Bowel Diseases

(2013) Gaetano Bergamaschi et al.   INFLAMMATORY BOWEL DISEASES

Hepcidin is a key mediator of anemia of inflammation in Crohn's disease

(2012) Robert J. Basseri et al.   Journal of Crohns & Colitis

Monoclonal anti-TNF antibodies can elevate hemoglobin level in patients with ankylosing spondylitis

(2012) Cemal Bes et al.   RHEUMATOLOGY INTERNATIONAL

Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease

(2011) Pantelis Oustamanolakis et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Pathogenesis and treatment of anemia in inflammatory bowel disease

(2010) G. Weiss et al.   HAEMATOLOGICA

Serum prohepcidin levels in chronic inflammatory bowel diseases

(2010) Judit Nagy et al.   Journal of Crohns & Colitis

Hepcidin Serum Levels and Resistance to Recombinant Human Erythropoietin Therapy in Haemodialysis Patients

(2009) Elísio Costa et al.   ACTA HAEMATOLOGICA

Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

(2009) Paul Emery et al.   ARTHRITIS AND RHEUMATISM

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications

(2009) I. Theurl et al.   BLOOD

Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis

(2009) Jayantha Arnold et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-  treatment

(2009) G. Bergamaschi et al.   HAEMATOLOGICA

Classification of anemia for gastroenterologists

(2009) Jose Antonio Moreno Chulilla et al.   WORLD JOURNAL OF GASTROENTEROLOGY

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

(2008) E.F. Stange et al.   Journal of Crohns & Colitis